mynth
← DATABASE
12/2021

KAVO DENTAL acquired by PLANMECA GROUP

GERMANY Life Sciences / Medical Devices EV 300M - 700M EUR

Context

Planmeca has successfully finalized the acquisition of the treatment unit and instrument business from a major diversified global medical manufacturer. This strategic transaction represents a significant consolidation of the global dental equipment market, bringing together two of the most technically advanced portfolios in the industry. The strategic rationale for the move centers on the high degree of industrial synergy between the target’s mechanical instrumentation excellence and the group's existing strength in digital 3D imaging and software interfaces. By integrating the target’s renowned heritage and manufacturing capabilities, the group establishes itself as a dominant single-source provider for complete dental operatory solutions. The acquisition includes the full transfer of iconic branding and intellectual property, allowing the organization to capitalize on a massive global installed base. The partnership is designed to accelerate the development of "connected" dental suites, where high-precision handpieces are synchronized with digital diagnostic platforms. This integration reinforces the group’s standing as a primary technical enabler for dental professionals, ensuring long-term technical durability and operational caliber across its international operational hubs.

KAVO DENTAL, which reported an EBITDA margin of in 2020, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

KaVo Dental is a globally recognized industrial leader specializing in the development and manufacturing of high-performance dental instruments and comprehensive treatment centers. The organization's business model is built on a legacy of technical precision, producing a wide array of specialized handpieces, turbines, and integrated operatory units. Its value proposition is centered on ergonomic excellence, mechanical durability, and the integration of optical and fluid dynamic technologies into clinical workflows. Strategically, the firm focuses on the premium segment of the dental market, where it provides the foundational hardware required for high-stakes restorative and preventative procedures. By maintaining a focus on technical reliability and engineering innovation, the entity facilitates the operational efficiency of dental practices worldwide. The organization operates as a critical technical partner for practitioners seeking industrialized quality in medical instrumentation.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2020
2019

Similar deals in Life Sciences

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
01/2022PERMIRABIO PRODUCTS LABORATORY (BPL)UNITED KINGDOMCDMO
01/2022ANJAC BEAUTY & HEALTHAPOLLO HEALTHCARE CORP.CANADACDMO
12/2021INTEGEROSCORUNITED STATESImplants & Prosthetics
12/2021WINNCAREPHARMAOUEST INDUSTRIESFRANCEMedical Devices
12/2021THE CARLYLE GROUP / GTCRRESONETICSUNITED STATESMedical Devices
11/2021COLOPLASTATOS MEDICALSWEDENMedical Consumables
09/2021PERRIGO COMPANYHRA PHARMAFRANCEGenerics / Labs
07/2021ORKLANUTRAQNorwayNutrition & Dietary Supplements
07/2021MONTAGU PRIVATE EQUITYINTECH MEDICALFRANCEImplants & Prosthetics
07/2021PARTNERS GROUPPHARMATHENGREECECDMO

REFERENCES

Valuation range: EV 300M - 700M EUR

Revenue range: 250M - 500M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of KAVO DENTAL by PLANMECA GROUP are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: kavo dental

Acquirer: planmeca group